Strissel K J, Rinehart W B, Fini M E
Massachusetts General Hospital-Harvard Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown 02129.
Invest Ophthalmol Vis Sci. 1995 Jan;36(1):151-62.
To determine the molecular mechanisms whereby substances released by corneal epithelial cells act to inhibit the elaboration of collagenolytic activity by corneal stromal cells and to determine whether inhibitory activity might be mediated by interleukin-1 receptor antagonist (IL-1ra) or transforming growth factor (TGF)-beta.
Conditioned media were generated from primary cultures of rabbit corneal epithelial cells, from passaged cultures of rabbit corneal stromal fibroblasts, and from cells of the rabbit corneal epithelial cell line, SIRC. Pure populations of stromal cells were isolated from rabbit cornea and used directly for bioassay of the conditioned media to detect substances that inhibit collagenase synthesis. The mink lung epithelial cell line, Mv1Lu, was used for bioassay of TGF-beta-like activity. The addition of specific neutralizing antisera to bioassays allowed an assessment of the contribution of each isoform to the net regulatory activity. Reverse transcription-polymerase chain reaction and Northern blot analysis were employed to detect the presence of IL-1ra or TGF-beta mRNA species in cells from cultures used to generate conditioned media.
Both stimulatory and inhibitory substances that regulate the synthesis of stromal cell collagenase are released by corneal epithelial cells in primary culture. In contrast, only stimulatory activity is produced by corneal fibroblasts or SIRCs. MRNAs for a TGF-beta isoform, TGF-beta 2, and IL-1ra were identified in epithelial cells. Stromal fibroblasts also expressed TGF-beta 2 mRNA, but no evidence was found for expression of TGF-beta 3 mRNA in any of the three cell types. TGF-beta 2 is released by epithelial cells in both active and latent forms. This cytokine mediates the major portion of the net inhibitory activity against stromal cell collagenase synthesis produced by corneal epithelial cells.
This study demonstrates the expression of TGF-beta 2 and IL-1ra by corneal epithelial cells in culture. It is the TGF-beta 2 that acts as the major inhibitor of collagenase synthesis by corneal stromal cells in culture. However, IL-1ra and TGF-beta 2 are likely to play important roles in epithelial-mesenchymal interactions regulating corneal development, homeostatic maintenance, and repair.
确定角膜上皮细胞释放的物质抑制角膜基质细胞产生胶原酶活性的分子机制,并确定抑制活性是否可能由白细胞介素-1受体拮抗剂(IL-1ra)或转化生长因子(TGF)-β介导。
从兔角膜上皮细胞原代培养物、兔角膜基质成纤维细胞传代培养物以及兔角膜上皮细胞系SIRC的细胞中制备条件培养基。从兔角膜中分离出纯的基质细胞群体,直接用于条件培养基的生物测定,以检测抑制胶原酶合成的物质。貂肺上皮细胞系Mv1Lu用于TGF-β样活性的生物测定。在生物测定中加入特异性中和抗血清,可评估每种异构体对净调节活性的贡献。采用逆转录-聚合酶链反应和Northern印迹分析来检测用于制备条件培养基的培养细胞中IL-1ra或TGF-β mRNA种类的存在。
原代培养的角膜上皮细胞释放调节基质细胞胶原酶合成的刺激和抑制物质。相比之下,角膜成纤维细胞或SIRC仅产生刺激活性。在上皮细胞中鉴定出一种TGF-β异构体TGF-β2和IL-1ra的mRNA。基质成纤维细胞也表达TGF-β2 mRNA,但在这三种细胞类型中的任何一种中均未发现TGF-β3 mRNA表达的证据。TGF-β2以活性和潜伏形式由上皮细胞释放。这种细胞因子介导了角膜上皮细胞对基质细胞胶原酶合成的净抑制活性的主要部分。
本研究证明培养的角膜上皮细胞表达TGF-β2和IL-1ra。在培养中,TGF-β2是角膜基质细胞胶原酶合成的主要抑制剂。然而,IL-1ra和TGF-β2可能在调节角膜发育、稳态维持和修复的上皮-间充质相互作用中发挥重要作用。